Open AccessMedicineMaterials Science
D. Geller, Jeffry G Weers, S. Heuerding
2011.7.29Journal of Aerosol Medicine and Pulmonary Drug Delivery
tlooto Summary
A dry powder formulation of tobramycin for the treatment of chronic pulmonary Pseudomonas aeruginosa infection in CF patients provides substantially improved intrapulmonary deposition efficiency, faster delivery, and more convenient administration over nebulized formulations.
Abstract
Abstract is not available.
Citation format
GELLER, D.; WEERS, Jeffry G; HEUERDING, S. Development of an inhaled dry-powder formulation of tobramycin using pulmosphere™ technology. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 2011, 24: 175–182.